A novel transcranial photobiomodulation device to address motor signs of Parkinson’s disease: a parallel randomised feasibility study

Emerging evidence is increasingly supporting the use of transcranial photobiomodulation (tPBM) to improve symptoms of neurodegenerative diseases, including Parkinson’s disease (PD)

Transcranial Photobiomodulation Treatment: Significant Improvements in Four Ex-Football Players with Possible Chronic Traumatic Encephalopathy

Photobiomodulation with Near Infrared Light Helmet in a Pilot, Placebo Controlled Clinical Trial in Dementia Patients Testing Memory and Cognition

Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof of concept study

Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson’s Disease: A Case Series Conducted During COVID-19

Transcranial Photobiomodulation Treatment Effects in Former Athletes with Repetitive Head Hits

Tug McGraw Foundation-Supported Study Provides Hope for Improving Cognitive Function in Veterans

Let there be light – Study led by Mass. General suggests light therapy is safe and may help patients with moderate brain injury

Effect of Transcranial Low-Level Light Therapy vs Sham Therapy Among Patients With Moderate Traumatic Brain Injury: A Randomized Clinical Trial

Effects of Home Photobiomodulation Treatments on Cognitive & Behavioral Function, Cerebral Perfusion and Resting-State Functional Connectivity in Patients with Dementia

Pulsed Near Infrared Transcranial and Intranasal Photobiomodulation Significantly Modulates Neural Oscillations